On Thursday, June 2, 2016, the FDA hosted a webinar to share general information about how the FDA regulates diabetes devices and ongoing efforts to accelerate the availability of artificial pancreas devices. The webinar focused on current and emerging artificial pancreas technologies, and the FDA’s role in reviewing these technologies for safety and effectiveness. Representatives from the FDA and the Diabetes Patient Advocacy Coalition were available to answer questions from webinar participants.
Registration is not necessary.
Date: Thursday, June 2, 2016
Time: 2:00 – 3:00 PM, Eastern Time
To ensure you are connected, please dial-in 15 minutes prior to the start of the webinar
To hear the presentation and ask questions:
Dial: 888-603-9738; passcode: 8218260 | International: 212-547-0409; passcode: 8218260
To view the webinar presentation you must download the free WebEx software plug-in:
- Before the webinar, visit the WebEx Downloads webpage
- Under the WebEx Event Manager heading select the download for your operating system.
On the day of the webinar, use the following link to view the presentation:
Following the webinar, a transcript and the video recording will be available at: http://www.fda.gov/CDRHWebinar
NOTE: The FDA does not provide Continuing Education (CEU) or Certificates of Attendance for webinar attendance.
Target Audience: Diabetes Patient Groups
If you have any general questions about the FDA’s regulation of medical devices, please contact CDRH’s Division of Industry and Consumer Education (DICE) at email@example.com, 1-800-638-2041, or 301-796-7100.
Food and Drug Administration
Center for Devices and Radiological Health